“With another fast-to-market example of our successful execution, we are pleased to offer relief and comfort to 60,000 certified patients in Massachusetts,” said Charles Bachtell, CEO and cofounder of Cresco Labs. “Massachusetts is a robust and fast growth cannabis market, and HHH expects its first pilot harvest from its Fall River cultivation facility towards the end of the first quarter. Cresco has applied for adult use licensing for our Fall River dispensary, which opened today with a selection of medical-grade cannabis vape cartridges, edibles, tinctures, topicals, concentrates, and flower from three Massachusetts cultivators.”
Patients can purchase up to 10 ounces every two months after being certified by a physician for any one of the Massachusetts state-approved debilitating medical conditions. Cresco Labs’ core mission of patient education and outreach will help inform patients about using medical cannabis as medicine through private one-on-one consultations.
HHH has licensing that allows for cultivation, manufacturing, processing and the establishment and operation of a medical cannabis dispensary, with the ability to obtain up to two additional medical cannabis dispensary licenses and three adult-use dispensary licenses.
The Hope Heal Health Dispensary, located at 1 West Street in Fall River, MA, is open daily, 10:00 am to 7:00 pm. For more information call 774-377-9333.
About Cresco Labs:
Cresco Labs, based in Chicago, is a leading U.S. cannabis company with experienced management, access to capital and a demonstrated growth strategy. As a differentiated grower, processor and retailer of premium cannabis operating in seven states, the company focuses on entering highly regulated markets with outsized demand potential and high barriers to entry. Its impressive speed-to-market gives Cresco a distinct competitive advantage as it replicates its model to expand its national footprint. Cresco’s proven ability to execute is complemented by a cutting-edge brand strategy spearheaded by several of the brightest minds in consumer marketing in the nation. Cresco’s products are tailored to all major consumer segments: everyday cannabis, medicinally focused, connoisseur grade, and chef inspired edibles by James Beard Award-winning pastry chef Mindy Segal. Learn more about Cresco Labs at crescolabs.com.
Forward Looking Statements
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’ ‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’ ‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the negative of those forms or other comparable terms. The Company’s forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under “Risk Factors” in the company’s CSE Listing Statement filed with SEDAR; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company’s forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco’s shares, nor as to the Company’s financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company’s forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise.